499 related articles for article (PubMed ID: 27834689)
21. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
[TBL] [Abstract][Full Text] [Related]
22. Map3k8 Modulates Monocyte State and Atherogenesis in ApoE-/- Mice.
Sanz-Garcia C; Sánchez Á; Contreras-Jurado C; Cales C; Barranquero C; Muñoz M; Merino R; Escudero P; Sanz MJ; Osada J; Aranda A; Alemany S
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):237-246. PubMed ID: 27856455
[TBL] [Abstract][Full Text] [Related]
23. Attenuated atherogenesis in apolipoprotein E-deficient mice lacking amyloid precursor protein.
Van De Parre TJ; Guns PJ; Fransen P; Martinet W; Bult H; Herman AG; De Meyer GR
Atherosclerosis; 2011 May; 216(1):54-8. PubMed ID: 21316678
[TBL] [Abstract][Full Text] [Related]
24. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
25. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in
Ray M; Gabunia K; Vrakas CN; Herman AB; Kako F; Kelemen SE; Grisanti LA; Autieri MV
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1297-1308. PubMed ID: 29674474
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.
Kooijman S; Meurs I; van der Stoep M; Habets KL; Lammers B; Berbée JF; Havekes LM; van Eck M; Romijn JA; Korporaal SJ; Rensen PC
J Thromb Haemost; 2015 Jan; 13(1):126-35. PubMed ID: 25345495
[TBL] [Abstract][Full Text] [Related]
27. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
28. Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice.
Zhang J; Chen H; Liu L; Sun J; Shi MA; Sukhova GK; Shi GP
Cardiovasc Res; 2012 Dec; 96(3):543-51. PubMed ID: 22871590
[TBL] [Abstract][Full Text] [Related]
29. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
30. Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient mice.
Pulakazhi Venu VK; Uboldi P; Dhyani A; Patrini A; Baetta R; Ferri N; Corsini A; Muro AF; Catapano AL; Norata GD
Thromb Haemost; 2015 Jul; 114(1):186-97. PubMed ID: 25881051
[TBL] [Abstract][Full Text] [Related]
31. P-Selectin Expressed by a Human SELP Transgene Is Atherogenic in Apolipoprotein E-Deficient Mice.
Zhang N; Liu Z; Yao L; Mehta-D'souza P; McEver RP
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1114-21. PubMed ID: 27102967
[TBL] [Abstract][Full Text] [Related]
32. Stimulatory effects of cardiotrophin 1 on atherosclerosis.
Konii H; Sato K; Kikuchi S; Okiyama H; Watanabe R; Hasegawa A; Yamamoto K; Itoh F; Hirano T; Watanabe T
Hypertension; 2013 Nov; 62(5):942-50. PubMed ID: 24041953
[TBL] [Abstract][Full Text] [Related]
33. Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E
Rinne P; Kadiri JJ; Velasco-Delgado M; Nuutinen S; Viitala M; Hollmén M; Rami M; Savontaus E; Steffens S
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):313-323. PubMed ID: 29284608
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.
Wei Y; Zhu M; Corbalán-Campos J; Heyll K; Weber C; Schober A
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):796-803. PubMed ID: 25810298
[TBL] [Abstract][Full Text] [Related]
35. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
[TBL] [Abstract][Full Text] [Related]
36. Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy.
Chen K; Yuan R; Zhang Y; Geng S; Li L
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28396568
[TBL] [Abstract][Full Text] [Related]
37. TSP-1 (Thrombospondin-1) Deficiency Protects ApoE
Ganguly R; Khanal S; Mathias A; Gupta S; Lallo J; Sahu S; Ohanyan V; Patel A; Storm K; Datta S; Raman P
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):e112-e127. PubMed ID: 33327743
[TBL] [Abstract][Full Text] [Related]
38. G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE
Qian L; Ma L; Wu G; Yu Q; Lin H; Ying Q; Wen D; Gao C
Vascul Pharmacol; 2017 Feb; 89():49-57. PubMed ID: 28069546
[TBL] [Abstract][Full Text] [Related]
39. Intermedin
Ren JL; Hou YL; Ni XQ; Zhu Q; Chen Y; Zhang LS; Liu X; Xue CD; Wu N; Yu YR; Tang CS; Ning ZP; Chai SB; Qi YF
J Cardiovasc Pharmacol Ther; 2020 May; 25(3):251-264. PubMed ID: 31698947
[TBL] [Abstract][Full Text] [Related]
40. c-Kit suppresses atherosclerosis in hyperlipidemic mice.
Song L; Zigmond ZM; Martinez L; Lassance-Soares RM; Macias AE; Velazquez OC; Liu ZJ; Salama A; Webster KA; Vazquez-Padron RI
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H867-H876. PubMed ID: 31441677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]